Jefferies reiterated a Buy rating on Varian Medical Systems VAR and lowered its price target from $74 to $65.
Jefferies noted, “VAR posted mixed F3Q with revenues $5mn light but EPS $0.03 on sequential margin improvement. However, orders were weaker and guidance was lowered for second consecutive Q mainly on F/X headwinds. We are cutting forecasts and PT to $65 to account for F/X pressures, the pending 2.3% Med-tech tax, and further uncertainty surrounding orders based on reimbursement and competition.”
Varian Medical Systems closed at $57.31 on Wednesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in